What are the advantages of pharmaceutical out-licensing with Unither?

In the pharmaceutical industry, out-licensing allows a company to commercialize a product developed by a third party under license or through an assignment of rights, without going through the full R&D process. This allows stakeholders to rapidly extend their market reach and product ranges without having to worry about regulatory aspects. Unither Pharmaceuticals has a unique portfolio of out-licensing products, in addition to its CDMO activity.

Our turnkey products allow our partners to focus on marketing and distribution while we handle production and compliance.